chr3-194604358-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001011655.3(TMEM44):c.1105G>A(p.Val369Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000275 in 1,567,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001011655.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000195 AC: 34AN: 174708Hom.: 0 AF XY: 0.000139 AC XY: 13AN XY: 93360
GnomAD4 exome AF: 0.000282 AC: 399AN: 1415646Hom.: 0 Cov.: 33 AF XY: 0.000279 AC XY: 195AN XY: 699972
GnomAD4 genome AF: 0.000210 AC: 32AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2023 | The c.1246G>A (p.V416I) alteration is located in exon 10 (coding exon 10) of the TMEM44 gene. This alteration results from a G to A substitution at nucleotide position 1246, causing the valine (V) at amino acid position 416 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at